To more directly examine the immunological effects of combination treatment in tumor-bearing mice, we performed a series of studies varying the relative timing of vaccination and CTLA-4 blockade, in either non-transgenic or tumor-bearing ProHA × TRAMP mice. This evidence concerns the gene CTLA4 and neoplasm.